In cervical cancers, nucleolin modulates the expression of MDR1 in a YB1-dependent manner precipitating chemoresistance by augmenting drug efflux and reducing intra-cellular accumulation of the drug (Ke et al., 2021). Here, NUCLEOLIN is linked to cervical cancer.